Stay updated on Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded system Revision: v3.4.2 and removed the funding notice Revision: v3.4.1. No study data or page content were changed; (To avoid being alerted by small changes, set an alert condition by clicking below.)SummaryDifference0.4%

- Check27 days agoChange DetectedNotice about government funding lapse and NIH Clinical Center status added at the top of the page. Page revision updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check34 days agoChange DetectedAdded a Show glossary feature to improve readability. Minor metadata updates were made, including capitalization changes in labels and a new Revision: v3.4.0 replacing v3.3.4.SummaryDifference0.2%

- Check48 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4, indicating a minor update to the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check70 days agoChange DetectedLocations section now includes California as a listed site (San Francisco, California), and the page revision is updated to v3.3.3.SummaryDifference0.2%

- Check98 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Capecitabine+Bevacizumab in MSS Colorectal Cancer Clinical Trial page.